Lantern Pharma Inc.
LTRN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $34 | $46 | $66 | $87 |
| - Cash | $8 | $22 | $37 | $52 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $27 | $25 | $28 | $36 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$22 | -$16 | -$14 | -$13 |
| % Margin | – | – | – | – |
| Net Income | -$21 | -$16 | -$14 | -$12 |
| % Margin | – | – | – | – |
| EPS Diluted | -1,930.92 | -1.47 | -1.31 | -1.13 |
| % Growth | -131,255.1% | -12.2% | -15.9% | – |
| Operating Cash Flow | -$18 | -$14 | -$13 | -$11 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$18 | -$14 | -$13 | -$11 |